|Mr. Chuyuan Li||Exec. Chairman||N/A||N/A||1966|
|Mr. Hong Li||GM & Exec. Director||225.31k||N/A||1967|
|Ms. Ning Cheng||Vice Chairman||N/A||N/A||1966|
|Mr. Jun Yang||Vice Chairman||N/A||N/A||1970|
|Mr. Changhai Wu||Deputy GM & Exec. Director||214.72k||N/A||1966|
|Ms. Juyan Liu||Exec. Director||N/A||N/A||1964|
|Mr. Zhang Chunbo||Deputy GM & Exec. Director||179.29k||N/A||1977|
|Mr. Haiwen Huang||Deputy Gen. Mang.||N/A||N/A||1981|
|Ms. Haoshan Zheng||Deputy GM & Director of Bus. Admin. Department||N/A||N/A||1976|
|Mr. Jianxiong Zheng||Deputy Gen. Mang.||N/A||N/A||1970|
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and chemical raw material intermediates in the People's Republic of China and internationally. It operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Others. The company is also involved in the wholesale, retail, import, and export of Western and Chinese medicines, and medical apparatus and instruments; and research and development, production, and sale of beverages, food, healthcare products, pre-packaging food, dairy products, ganoderma spore oil capsules, lozenges, tortoise herb jelly, etc. In addition, it invests in health industry, such as medical care, health management, health preservation, elderly care, etc.; and provides commercial and advertising services. As of December 31, 2020, the company had 141 retail chain pharmacy outlets, which included 27 Cai Zhi Lin pharmacy outlets, 33 Jian Min pharmacy outlets, 36 GPC Prescription Pharmacy outlets, and 24 Hainan Guangyao Chenfei Pharmaceutical Chain outlets, as well as 21 retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited’s ISS governance QualityScore as of 26 September 2021 is 3. The pillar scores are Audit: 8; Board: 4; Shareholder rights: 5; Compensation: 1.